---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-049879"
form_type: "8-K"
ticker: "KALV"
cik: "0001348911"
company_name: "KalVista Pharmaceuticals, Inc."
filed_at: "2021-10-04T23:59:59+00:00"
generated_at: "2026-06-28T23:20:10.408748+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# KalVista stockholders elect three Class III directors at 2021 annual meeting

## Summary
- Elected Albert Cha, Martin Edwards, and Nancy Stuart as Class III directors for three-year terms expiring 2024.
- Ratified Deloitte & Touche as independent auditor for fiscal year ending April 30, 2022: 22.6M for, 13.6K against.
- Approved non-binding advisory vote on named executive officer compensation: 19.7M for, 2.5M against.
- All proposals passed; broker non-votes were 464,900 on director elections and compensation vote.

## SEC filing metadata
- accession: 0001564590-21-049879
- form_type: 8-K
- ticker: KALV
- cik: 0001348911
- company_name: KalVista Pharmaceuticals, Inc.
- filed_at: 2021-10-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348911/000156459021049879/0001564590-21-049879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348911/000156459021049879/kalv-8k_20210930.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-049879
- JSON: https://secwatch.observer/filing/0001564590-21-049879.json
- Plain text: https://secwatch.observer/filing/0001564590-21-049879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.